Key Data

Bayer Group Key Data

    
  1st Quarter
2014
1st Quarter
2015
Change Full Year
2014
  € million € million % € million
Sales 10,555 12,117 +14.8 42,239
Change (adjusted for currency and portfolio effects)     +2.7 +7.2 
         
Change in sales        
Volume +8.8% +2.8%   +6.8%
Price -0.4% -0.1%   +0.4%
Currency -5.8% +7.4%   -2.8%
Portfolio +0.2% +4.7%   +0.8%
         
EBIT 1 2,096 1,998 -4.7 5,506
Special items 7 (244)   (438)
EBIT before special items2 2,089 2,242 +7.3 5,944
         
EBIT margin before special items 3 19.8% 18.5%   14.1%
         
EBITDA4 2,745 2,804 +2.1 8,442
Special items 7 (196)   (370)
EBITDA before special items 2 2,738 3,000 +9.6 8,812
         
EBITDA margin before special items 3 25.9% 24.8%   20.9%
         
Financial result (159) (274) -72.3 (981)
         
Net income 1,423 1,303 -8.4 3,426
Earnings per share (€)5 1.72 1.58 -8.1 4.14
Core earnings per share (€) 6 1.95 2.10 +7.7 6.02
         
Gross cash flow 7 2,048 2,060 +0.6 6,820
         
Net cash flow 8 163 724 . 5,810
         
Cash outflows for capital expenditures 357 345 -3.4 2,371
         
Research and development expenses 820 956 +16.6 3,574
         
Depreciation, amortization and impairments 649 806 +24.2 2,936
         
Number of employees at end of period9 113,885 119,478 +4.9 118,888
Personnel expenses (including pension expenses) 2,423 2,924 +20.7 9,845

2014 figures restated
In some cases, the sum of the figures given in this report may not precisely equal the stated totals and percentages may not be exact due to rounding.

1 EBIT = earnings before financial result and taxes

2 EBIT before special items and EBITDA before special items are not defined in the International Financial Reporting Standards and should therefore be regarded only as supplementary information. EBITDA before special items is a meaningful indicator of operating performance since it is not affected by depreciation, amortization, impairments or special items. By reporting this indicator, the company aims to give readers a clear picture of the results of operations and ensure comparability of data over time. See also Chapter 6 “Calculation of EBIT(DA) Before Special Items.”

3 The EBIT(DA) margin before special items is calculated by dividing EBIT(DA) before special items by sales.

4 EBITDA = EBIT plus amortization and impairment losses on intangible assets and depreciation and impairment losses on property, plant and equipment, minus impairment loss reversals

5 Earnings per share as defined in IAS 33 = adjusted net income divided by the average number of shares

6 Core earnings per share are not defined in the International Financial Reporting Standards. By reporting this indicator, the company aims to give readers a clear picture of the results of operations and ensure comparability of data over time. The calculation of core earnings per share is explained in Chapter 7 “Core Earnings Per Share.”

7 Gross cash flow = income after income taxes, plus income taxes, plus financial result, minus income taxes paid or accrued, plus depreciation, amortization and impairment losses, minus impairment loss reversals, plus/minus changes in pension provisions, minus gains/plus losses on retirements of noncurrent assets, minus gains from the remeasurement of already held assets in step acquisitions. The change in pension provisions includes the elimination of non-cash components of EBIT. It also contains benefit payments during the year. For details see Chapter 8 “Financial Position of the Bayer Group.”

8 Net cash flow = cash flow from operating activities according to IAS 7

9 Full-time equivalents

Last updated: August 16, 2017  Copyright © Bayer AG
http://www.quarterly-report-2015-q1.bayer.com